Developing advanced tools for analyzing single-cell genetic experiments

Robust and scalable Bayesian analysis tools for single cell CRISPR screens with sequencing- and imaging-based readouts

['FUNDING_FELLOWSHIP'] · HARVARD MEDICAL SCHOOL · NIH-10891780

This study is working on new tools to help scientists better understand how genetic changes affect cell behavior, which could lead to improved treatments for conditions like Amyotrophic Lateral Sclerosis.

Quick facts

Phase['FUNDING_FELLOWSHIP']
Study typeNih_funding
SexAll
SponsorHARVARD MEDICAL SCHOOL (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-10891780 on ClinicalTrials.gov

What this research studies

This research focuses on improving the analysis of single-cell CRISPR screens, which allow scientists to study how genetic changes affect cell behavior at an unprecedented level of detail. The project will create two innovative tools that utilize Bayesian hierarchical models to efficiently analyze large datasets generated from these experiments, including both sequencing and imaging data. By enhancing the computational methods used to interpret complex genetic information, this research aims to provide clearer insights into cellular functions and responses. Patients may benefit from the findings as they could lead to better understanding and treatment options for conditions like Amyotrophic Lateral Sclerosis.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals affected by genetic disorders, particularly those with Amyotrophic Lateral Sclerosis.

Not a fit: Patients with non-genetic conditions or those not affected by diseases related to genetic perturbations may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for genetic diseases by providing deeper insights into cellular mechanisms.

How similar studies have performed: Previous research has shown promise in using Bayesian methods for complex data analysis, indicating potential success for this novel approach.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Amyotrophic Lateral Sclerosis Motor Neuron Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.